Ignite Creation Date:
2024-05-05 @ 10:37 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01153620
Status:
COMPLETED
Last Update Posted:
2012-04-06
First Post:
2010-06-29
Brief Title:
The Antiseptic Efficacy and Tolerability of Lavasept 004 on Acute Traumatic Wounds
Sponsor:
B Braun Ltd Centre of Excellence Infection Control
Organization:
B Braun Ltd Centre of Excellence Infection Control
Study Overview
Official Title:
Randomized Double-blind Controlled Clinical Trial on the Antiseptic Efficacy and Tolerability of Lavasept 004 on Acute Traumatic Wounds
Status:
COMPLETED
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Lavasept 2
Brief Summary:
The primary objective of the study is to assess the antiseptic efficacy of Lavasept 004 when used as an antiseptic agent and to compare these with Ringers solution in patients with acute traumatic wounds
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None